“GLP-1 RECEPTOR AGONISTS BEYOND OBESITY: EXPANDING HORIZONS IN CARDIOMETABOLIC, RENAL, AND NEUROLOGICAL DISEASE” (2026) International journal of medical sciences, 6(4), pp. 849–855. doi:10.55640/.